Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 3.230% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) C[C@H](NC(=O)c1[nH]cnc1C(=O)Nc1ccccc1)c1ccccc1
b) Cc1cc(OC(=O)c2c(C)cc(O)cc2O)cc(O)c1C(=O)O
Answer: a. C[C@H](NC(=O)c1[nH]cnc1C(=O)Nc1ccccc1)c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C[C@H](NC(=O)c1[nH]cnc1C(=O)Nc1ccccc1)c1ccccc1
C[C@H](NC(=O)c1[nH]cnc1C(=O)Nc1ccccc1)c1ccccc1
4-N-phenyl-5-N-[(1S)-1-phenylethyl]-1H-imidazole-4,5-dicarboxamide